Verition Fund Management’s Alexion Pharmaceuticals ALXN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-380,182	Closed	-$69.8M	–	2573
2021 Q2	$69.8M	Buy	380,182 +228,374	+150%	+$39.2M	1.03%	33
2021 Q1	$23.2M	Buy	151,808 +1,707	+1%	+$264K	0.42%	48
2020 Q4	$23.5M	Buy	150,101 +140,456	+1,456%	+$18M	0.36%	80
2020 Q3	$1.1M	Sell	9,645 -1,742	-15%	-$188K	0.04%	358
2020 Q2	$1.28M	Buy	+11,387	New	+$1.21M	0.06%	338
2020 Q1	–	Sell	-9,131	Closed	-$988K	–	1211
2019 Q4	$988K	Sell	9,131 -136	-1%	-$14.5K	0.03%	453
2019 Q3	$908K	Sell	9,267 -11,967	-56%	-$1.35M	0.05%	438
2019 Q2	$2.78M	Buy	21,234 +8,560	+68%	+$1.1M	0.14%	178
2019 Q1	$1.71M	Sell	12,674 -5,843	-32%	-$727K	0.09%	254
2018 Q4	$1.8M	Buy	18,517 +16,362	+759%	+$1.93M	0.15%	146
2018 Q3	$300K	Sell	2,155 -945	-30%	-$119K	0.01%	1032
2018 Q2	$385K	Buy	3,100 +919	+42%	+$107K	0.03%	785
2018 Q1	$243K	Buy	+2,181	New	+$261K	0.02%	920
2017 Q4	–	Sell	-3,835	Closed	-$538K	–	1359
2017 Q3	$538K	Buy	+3,835	New	+$521K	0.05%	539
2017 Q2	–	Sell	-1,757	Closed	-$213K	–	1415
2017 Q1	$213K	Buy	+1,757	New	+$227K	0.02%	1012
2016 Q4	–	Sell	-3,240	Closed	-$397K	–	1511
2016 Q3	$397K	Sell	3,240 -5,005	-61%	-$644K	0.05%	613
2016 Q2	$963K	Buy	+8,245	New	+$1.17M	0.14%	190
2015 Q2	–	Sell	-1,633	Closed	-$283K	–	760
2015 Q1	$283K	Buy	+1,633	New	+$296K	0.08%	217
2014 Q3	–	Sell	-2,830	Closed	-$442K	–	929
2014 Q2	$442K	Buy	2,830 +1,288	+84%	+$203K	0.07%	289
2014 Q1	$235K	Buy	+1,542	New	+$245K	0.05%	344
2013 Q4	–	Sell	-3,229	Closed	-$375K	–	721
2013 Q3	$375K	Buy	3,229 +823	+34%	+$90.3K	0.08%	263
2013 Q2	$222K	Buy	+2,406	New	+$232K	0.05%	461

Other funds holding ALXN